Apidra 3.49 mg/mL (equivalent to 100 Units/mL)
Country: Filippini
Lingwa: Ingliż
Sors: FDA (Food And Drug Administration)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Insulin Glulisine
Disponibbli minn:
Sanofi-Aventis Philippines, Inc.; Distributor: Sanofi-Aventis Philippines, Inc.
INN (Isem Internazzjonali):
Insulin Glulisine
Dożaġġ:
3.49 mg/mL (equivalent to 100 Units/mL)
Għamla farmaċewtika:
Solution for Subcutaneous/Continuous SC Pump Infusion/ Intravenous Injection
Unitajiet fil-pakkett:
10 mL Type I Colorless Glass Vial (Box of 1's), Type I colourless glass vial in 10mL (box of 1's)
Manifatturat minn:
Sanofi-Aventis Deutschland GmbH, Germany
Sommarju tal-prodott:
Solution for Subcutaneous/Continuous SC Pump Infusion/ Intravenous Injection
Data ta 'l-awtorizzazzjoni:
2021-02-26
